Bepotas Ophthalmic Solution

Bepotas Sterile Eye Drops is indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis.

Bepotastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from mast cells.

The recommended therapy is 1 drop of Bepotastine sterile Eye Drops in the affected eye(s) twice daily.

Pediatric Use: Safety and efficacy in pediatric patients below the age of 2 have not been established.

No drug interactions observed but patients who are sensitive to Bepotas molecule should be used with caution.

Bepotastine Sterile Eye Drops are contraindicated in patients hypersensitive to Bepotastine Besilate or any other component of the preparation.

The side effects have been reported in patients: Headache, mild eye irritation, unusual or unpleasant taste in the mouth.

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Bepotastine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Bepotastine is excreted in breast milk. Caution should be exercised when Bepotastine ophthalmic solution is administered to a nursing woman.

Before using Bepotas, tell your doctor if you are allergic to it. Bepotas should not be instilled while wearing contact lenses.

If you use more Bepotas eye drops than you should, rinse your eye with warm water. Do not put in any more drops until it is time for your next regular dose. Pharmaceutical Precautions

Ophthalmic Anti-allergic preparations

The drug is to be used within 30 days after first opening. Stored at 15º-25ºC Protect from light The bottle is to be closed tightly immediately after use.